M-Lab

M-Lab: A Strategic Collaboration Between MagIC and MicroSigX

M-Lab is a joint-research facility lab through a strategic partnership between MicroSigX and Microbiota I- Center (MagIC).

M-Lab serves as a dynamic bridge between upstream scientific discovery and downstream clinical application. Within this collaborative space, MagIC researchers work hand-in-hand with MicroSigX experts to accelerate the development of microbiome-based diagnostics and therapeutics.

The upstream innovations at MagIC lay the scientific foundation, while MicroSigX provides critical downstream expertise—guiding promising technologies through development, validation, and commercialization.

A Synergistic Model for Translational Microbiome Research

At M-Lab, MagIC leads upstream and midstream research efforts, including:

Discovering novel microbiome biomarkers and therapeutic targets
Filing patents and initiating licensing pathways for commercialization

Meanwhile, MicroSigX drives downstream development by:

Refining and optimizing technologies
Identifying manufacturing partners
Conducting clinical trials and navigating regulatory approvals

Our first joint initiative at M-Lab targets early diagnostic markers for Autism Spectrum Disorders (ASD), which has officially received FDA Breakthrough Device Designation. This milestone marks a significant step forward in acceleratingregulatory review and potential clinical adoption. The designation recognizes the innovation and potential impact of our approach in identifying ASD at earlier stages, helping to improve outcomes through timely intervention.

Bridging Science and Impact

Facilitating Regulatory Success

Navigating regulatory pathways requires deep market insight, policy expertise, and strategic execution. MicroSigX brings essential capabilities and networks that complement MagIC’s scientific strengths, enabling faster and more effective development of diagnostic solutions.

Overcoming Translational Barriers

M-Lab addresses two key challenges in bringing academic research to market:

Real-World Validation: Controlled lab findings often face hurdles in real-
world settings. M-Lab provides a platform to test and refine innovations in
practical environments.
Commercialization Know-How: Many researchers lack the business
acumen to translate discoveries into viable products. Through collaboration
with MicroSigX, MagIC scientists gain exposure to entrepreneurial thinking
and industry practices.

Advancing Microbiome Science Together

M-Lab exemplifies the power of interdisciplinary collaboration. By combining MagIC’s research excellence with MicroSigX’s translational capabilities, we are shaping the future of microbiome science—transforming discoveries into impactful solutions for global health.